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Abstract
Background/Purpose
Transarterial lead implantation in the left ventricle or aorta is a rare complication. Percutaneous 
lead removal is associated with significant thromboembolic and bleeding risk. We present two 
cases of lead removal  from the left  ventricle  via  the left  subclavian artery with concurrent 
carotid  embolic  protection  followed  by  stent  graft  placement  in  the  subclavian  artery.  
Methods/Results
Patient 1 underwent prior pacemaker implant with atrial and ventricular active fixation leads 
positioned in the right coronary cusp and the left ventricle, respectively. Patient 2 had prior 
ICD implant  with a single active fixation lead positioned in the left  ventricular  apex. Lead 
removal was performed in a hybrid operating room. Distal embolic filter wires were deployed 
in the carotid arteries following anticoagulation. Intravascular ultrasound of the left subclavian 
artery was performed and as the leads were withdrawn, a covered stent was deployed at the 
removal  site.  Final  angiography  demonstrated  no  evidence  of  embolic  phenomena.  Both 
patients  underwent  transvenous  lead  implantation  followed  by  an  uneventful  postoperative 
clinical  course.                                     
Conclusions
Transarterial  percutaneous  lead  removal  may  be  safely  performed  using  embolic  filter 
protection of the cerebral circulation and stent graft placement of the arterial entry site.        
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Introduction
Inadvertent transarterial lead implantation in the left ventricle or aorta is a rare but potentially 
serious complication of cardiac rhythm device implantation. Percutaneous lead removal may 
pose significant thromboembolic and bleeding risk. Rare literature reports describe several 
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different management approaches, including surgical removal or lifelong anticoagulation [1-3]. 
In cases of transvenous implants with subsequent inadvertent puncture of the ventricular or 
intratrial  septum  or  placement  via  a  preexisting  atrial  septal  defect,  with  resultant  lead 
positioning in the LV, transvenous removal has been successfully attempted. However, only 
rare  reports  of transarterial  lead removal  exist.  We present  two cases of percutaneous lead 
removal from the left ventricle and/or aorta via the left subclavian artery with a novel method 
employing carotid embolic protection followed by stent graft placement in the subclavian artery 
to  achieve  hemostasis.                                         
Case  1                                             
A 79 year old male with history of sick sinus syndrome associated with frequent syncopal 
events underwent dual lead pacemaker implantation with atrial and ventricular active fixation 
leads.  Six  months  post  implant  he  experienced  acute  inferolateral  ST-segment  elevation 
myocardial  infarction  complicated  by  cardiogenic  shock and underwent  successful  primary 
percutaneous  revascularization.  During  diagnostic  coronary  angiography  the  angiographic 
catheters  were  identified  to  engage  the  previously  implanted  pacemaker  leads.  Inadvertent 
positioning of the atrial and ventricular leads via the left subclavian artery to the right coronary 
cusp  and  left  ventricular  apex,  respectively,  was  confirmed  with  detailed  fluoroscopy  and 
selective subclavian angiography. Pacemaker interrogation confirmed lack of atrial capture and 
normal ventricular sensing and capture thresholds. Following revascularization, the patient had 
an uneventful hospital  course and was discharged on appropriate  medical  therapy including 
antithrombotic  therapy  with aspirin  and thienopyridine.  Warfarin  was not  instituted  due  to 
persistent anemia and requirement of dual antiplatelet  therapy.                              
Given the high risk position of the atrial lead tip in close proximity to the right coronary artery 
ostium,  the  patient  was  electively  admitted  one  month  later  for  transarterial  lead  removal. 
Under  general  anesthesia  and  in  a  hybrid  operating  theater  and  catheterization  laboratory, 
vascular access was obtained in the right and left femoral arteries and right femoral vein. Prior 
to systemic anticoagulation, the left subpectoral pocket was opened under sterile conditions, 
and the subcutaneous tissue was carefully  dissected  until  the leads  were visible  and freed. 
Venipuncture  was  performed using  the  Seldinger  technique,  and the  left  axillary  vein  was 
accessed. Two active fixation pacemaker leads were implanted in the right ventricular outflow 
tract and the right atrial appendage, respectively. Fluoroscopy and aortography were performed 
demonstrating the dual pacemaker system (Figure 1). Aortic arch angiography demonstrated a 
type  1  arch  and  no  significant  disease  in  the  origin  of  the  great  vessels.  Using  5-French 
diameter,  90  cm  length  guiding  sheaths,  the  right  and  left  common  carotid  arterieswere 
selectively engaged over a guidewire. Carotid angiography revealed nonobstructive disease in 
the intracranial and extracranial portions bilaterally. Unfractionated heparin was administered 
to achieve an activated clotting time of approximately 350 seconds. A distal embolic filter wire 
(Spider, EV3 Inc., Plymouth, MN)was then deployed in the distal segment of the both internal 
carotid  arteries.  Selective  left  subclavian  angiography  was  then  performed,  confirming  the 
pacemaker leads entry point in the subclavian artery, but no critical subclavian arterial stenosis. 
Unfractionated heparin was administered to achieve an activated clotting time of approximately 
350 seconds.  
Stylets  were  then  advanced through the  chronic  transarterial  leads,  and after  retracting  the 
active fixation mechanism, gentle traction on the ventricular lead enabled withdrawal without 
requirement of laser extraction.  Similarly,  the atrial  lead was manually withdrawn from the 
aortic root, and both leads were carefully pulled back until the tips were in close proximity to 
the insertion site of the subclavian artery. Over an antegradeguidewire, intravascular ultrasound 
was  performed  to  ensure  appropriate  sizing  for  an  8mm  x  60  mm self-expanding  nitinol 
covered stent (Viabahn, W.L. Gore, Flagstaff, Arizona) placement. The stent was delivered and 
positioned between the proximal and distal insertion site margins and deployed immediately as 
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the leads were withdrawn (Figure 2). Angiography confirmed adequate stent expansion and no 
contrast  extravasation.  The distal  embolic  protection  devices  were subsequently withdrawn. 
Following  the  procedure,  the  patient  remained  hemodynamically  stable,  and  recovery  was 
uneventful without neurological or vascular complications.
Figure  1.  Aortic  root  aortography demonstrating the initial  atrial  lead  at  the  right  coronary  cusp  and initial  
ventricular lead at the LV apical wall. A new pacemaker system is also seen with the atrial lead at the right atrial  
appendage  and  ventricular  lead  at  the  RV  septum.                                        
Case  2                                                   
A 63 year old male with history of ischemic cardiomyopathy and single chamber ICD with a 
dual coil active fixation lead implanted twelve months prior to presentation, underwent routine 
echocardiography identifying the lead localized in the aortic root and crossing the aortic valve. 
The  proximal  coil  was  adjacent  to  the  right  coronary  cusp.  The  patient  had  recurrent 
gastrointestinal  bleeding  prohibiting  long  term  anticoagulation  therapy.  Considering  the 
thromboembolic risk of arterial lead placement and concern for adhesion near the ostium of the 
right coronary artery,  we opted to proceed with transarterial  lead extraction.  Under general 
anesthesia and in the hybrid operating room, the subpectoral pocket was exposed. Thoracic 
aortic  arch  and  carotid  angiography  was  performed,  and  distal  embolic  filter  wires  were 
deployed  in  the  right  and  left  internal  carotid  arteries  following  anticoagulation   with 
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unfractionated heparin. Intravascular ultrasound of the left subclavian artery was performed to 
localize the lead entry point at the left subclavian artery and determine appropriate reference 
vessel  sizing  for  stent  graft  placement.  As  the  lead  was  withdrawn,  a  covered  stent  was 
deployed at  the entry site  as  described previously.  There were no neurological  or  vascular 
complications following the procedure. Reimplantation of a cardiac resynchronization device 
was performed electively via the left subclavian vein without any complications. 
Figure 2. Covered stent deployment at the arterial insertion site during pacemaker lead withdrawal. 
Discussion
We report 2 cases of successful transarterial percutaneous lead removal using embolic filter 
protection  of  the  cerebral  circulation  and  stent  graft  placement  at  the  arterial  entry  site.  
Inadvertent cardiac rhythm device lead implantation via an arterial vessel is a rare event though 
it  may  be  widely  under  recognized  [1-3].  Removal  of  transarterially  positioned  leads  is 
associated with a high thromboembolic  risk as well  as increased risk of bleeding from the 
arterial  entry  site.  Further,  in  this  report,  lead  removal  posed  not  only  risk  of  ventricular 
perforation and development of tamponade, but also potential trauma to the coronary arteries, 
aorta  and aortic  valve.  Accordingly,  while  percutaneous  lead  removal  is  a  well-established 
technique, it remains unclear whether it can be safely performed from the arterial system. As 
such, conservative management with long-term anticoagulation is usually recommended, and 
surgical  removal  has  been  performed  when  conservative  management  is  not  an  option,  as 
proposed  by  current  guidelines  [4].                                          
Removal of chronic pacing leads percutaneously via the femoral artery [5] or via the subclavian 
artery  has  been  described  previously  and,  although  there  have  been  no  reports  of 
thromboembolic complications, the methods for removal vary and the number of reported cases 
is limited. Transesophageal echocardiography has been universally performed, and heparin is 
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instituted  in  patients  with  left  ventricular  lead  implants  to  minimize  the  risk  of  thrombus 
formation. However, given the direct communication with the systemic circulation, any lead 
manipulation  can  potentially  lead  to  systemic  embolization,  preferentially  in  the  cerebral 
circulation. With the technique presented herein, we utilized standard methodology employed 
in interventional cardiology for cerebral embolic protection and peripheral stent placement with 
excellent results. We demonstrate that stent deployment is readily feasible simultaneous with 
lead removal and provides immediate and effective hemostasis. This may provide a solution in 
cases where conventional  or laser sheaths are utilized resulting in expansion of the arterial 
puncture site. A technique employing a suture-based percutaneous closure device following 
transarterial lead removal from the subclavian artery has also been described, yet this method 
may only apply to cases for which no sheath is utilized for lead removal.                               
To our  knowledge,  this  is  the  first  description  of  transarterial  lead  removal  of  pacing and 
defibrillator leads with concomitant deployment of carotid embolic protection devices and stent 
graft placement for hemostasis at the removal site in the subclavian artery. This approach may 
effectively reduce the risk of systemic thromboembolism and arterial site bleeding associated 
with  transarterial  lead  removal.                                        
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